| Predicate |
Object |
| contentType |
Clinical Trial|Journal Article|Multicenter Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't |
| endingPage |
437 |
| issn |
1875-8908
1387-2877 |
| issueIdentifier |
2 |
| pageRange |
431-437 |
| publicationName |
Journal of Alzheimer's disease : JAD |
| startingPage |
431 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8e696e623b7822b80109521a53031ba7
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_38e1aca6fedafd1c948b31ce50dc41e2
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db3b0ac5510453817558fbbba0d209c7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b29abe85f886f68f5bbad81ccdaf223e |
| bibliographicCitation |
Barnes J, Bartlett JW, Fox NC, Schott JM. Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials. J Alzheimers Dis. 2013;34(2):431–7. doi: 10.3233/jad-121936. PMID: 23229078. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbd531334b7f9ce1b7595d716bc92b49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22b271d4a4d836567c22ff1a2edb7e12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3178-025X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_575abf4b6389e41c2fb13e4aa2c9d0d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c75ca19ff40297516a6a891cb8ff9502 |
| date |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/23229078
https://doi.org/10.3233/jad-121936 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1387-2877
https://portal.issn.org/resource/ISSN/1875-8908
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Targeted Recruitment Using Cerebrospinal Fluid Biomarkers: Implications for Alzheimer's Disease Therapeutic Trials |
| discusses |
http://id.nlm.nih.gov/mesh/M0023752 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D018579
http://id.nlm.nih.gov/mesh/D000544Q000628
http://id.nlm.nih.gov/mesh/D000544Q000134 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D015415Q000134
http://id.nlm.nih.gov/mesh/D059906Q000639
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008137
http://id.nlm.nih.gov/mesh/D000544Q000175
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_74215c9516abac826539f57c202449f0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6996
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 |